Transcode Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Transcode Therapeutics, Inc. has filed 318 SEC EDGAR filings since 18 Dec 2020

SEC filing history

Showing 76-100 of 318 matching filings.

Per page
25
Current page
4
10-K/A File 001-40363

FORM-10-K/A

Filing date
30 Apr 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
DEFA14A File 001-40363

DEFA14A

Filing date
21 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-40363

DEFA14A

Filing date
16 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40363

DEF 14A

Filing date
11 Apr 2025
Reporting date
21 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-40363

PRE 14A

Filing date
02 Apr 2025
Reporting date
02 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 001-40363

NT 10-K

Filing date
31 Mar 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-268764

424B5

Filing date
25 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-92695

SCHEDULE 13D filing

Filing date
20 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-92695

SCHEDULE 13G filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-40363

DEFA14A

Filing date
04 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-92695

SCHEDULE 13G filing

Filing date
03 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40363

DEF 14A

Filing date
30 Dec 2024
Reporting date
04 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-40363

PRE 14A

Filing date
19 Dec 2024
Reporting date
28 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-283668

EFFECT filing

Filing date
17 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .